Study of Urate Elevation in Parkinson's Disease, Phase 3

PHASE3CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Parkinson's Disease
Interventions
DRUG

Inosine

capsules containing 500 mg of inosine

DRUG

Placebo

capsules containing \~500 mg of lactose and appearing indistinguishable from inosine capsules

Trial Locations (62)

935

University of Puerto Rico, San Juan

10021

Weill Cornell Medical Center, New York

11203

SUNY Downstate Medical Center, Brooklyn

12208

Albany Medical College, Albany

13210

SUNY Upstate Medical University, Syracuse

15213

University of Pittsburgh, Pittsburgh

19107

University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore, Baltimore

21287

Johns Hopkins University, Baltimore

22908

University of Virginia, Charlottesville

23230

VCU Parkinson's & Movement Disorder Center (McGuire Veterans Hospital), Richmond

23456

Sentara Neurology Specialists, Virginia Beach

27705

Duke University, Durham

29403

Medical University of South Carolina, Charleston

30329

Emory University, Atlanta

30912

Augusta University, Augusta

33613

University of South Florida, Tampa

35233

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center, Nashville

38018

Wesley Neurology Clinic, PC, Cordova

38163

University of Tennessee Health Science Center, Memphis

40202

University of Louisville, Louisville

43221

Ohio State University, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

45219

University of Cincinnati/Cincinnati Children's Hospital, Cincinnati

46202

Indiana University, Indianapolis

48105

University of Michigan, Ann Arbor

48322

Henry Ford Health System, West Bloomfield

48824

Michigan State University, East Lansing

53226

Medical College of Wisconsin, Milwaukee

60190

Neurosciences Institute at Central DuPage Hospital, Winfield

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

70121

Oschner Clinic Foundation, New Orleans

76508

Baylor Scott & White Health, Temple

77030

Baylor College of Medicine, Houston

University of Texas Houston Medical School, Houston

80045

University of Colorado, Aurora

80113

Rocky Mountain Movement Disorder Center, Englewood

85013

Barrow Neurological Institute, Phoenix

85259

Mayo Clinic Arizona, Scottsdale

85351

Banner Sun Health Research Institute, Sun City

89106

Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas

90033

University of Southern California, Los Angeles

92093

University of California San Diego, La Jolla

94143

University of California San Francisco, San Francisco

95817

University of California Davis, Sacramento

97239

Oregon Health & Sciences University, Portland

99202

Inland Northwest Research, Spokane

Northwest Neurological PLLC, Spokane

06066

Hartford HealthCare Movement Disorders Center, Vernon

02114

Massachusetts General Hospital, Boston

02118

Boston University Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

07901

Overlook Medical Center, Atlantic Neuroscience Institute, Summit

02906

Butler Hospital, Providence

75390-9036

UT Southwestern Medical Center, Dallas

05405

The University of Vermont, Burlington

All Listed Sponsors
collaborator

The Parkinson Study Group

NETWORK

collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

collaborator

University of Rochester

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Michael Alan Schwarzschild

OTHER

NCT02642393 - Study of Urate Elevation in Parkinson's Disease, Phase 3 | Biotech Hunter | Biotech Hunter